All Articles

A new poll shows 81% of Americans fear tariffs will delay local projects, creating a funding crisis as costs rise and public opposition to new taxes grows.

In under two years, a premium cookie mix startup has landed on Target and Costco shelves. Here's how My Better Batch is rewriting the recipe for success.

A new report reveals a hidden public health crisis of loneliness among underserved boys, challenging how society views and supports male mental health.

A historic shift is underway in Canada's rental market. Slowing immigration and a construction boom are creating a surplus, giving tenants unprecedented choice.

Securities finance giant EquiLend's strategic investment in Digital Prime signals a major move to build institutional-grade infrastructure for tokenized assets.

NA beer leader Athletic Brewing partners with OpenTable to make mindful drinking easier at restaurants and launches innovative new lite and cocktail-inspired brews.

RainFocus launches its Base Module, a new toolkit aiming to streamline high-volume small events and unify customer data across an entire event portfolio.

PostcardMania's record year of charity isn't just altruism; it's a powerful business strategy that's boosting employee morale and reshaping local giving.

A $32 million contract for advanced sensors and processors will bolster U.S. armored vehicle survivability against modern battlefield threats like drones.

As biotech and pharma risks evolve, Verist Inc. launches tailored coverage, aiming to redefine insurance with a high-touch, data-driven service model.

DigitalChalk's learning platform is now on AWS Marketplace, simplifying software buying and accelerating workforce training for a new era of enterprise tech.

With social engineering attacks that trick users into copying malicious code up over 500%, a new tool aims to stop them by securing the browser itself.

With a fresh $35M led by CVS Health Ventures, Codoxo's generative AI platform aims to stop costly healthcare payment errors before they even happen.

Amid a lagging stock price, Western Uranium & Vanadium is launching a significant share buyback, signaling deep confidence in its undervalued assets.

A new report finds 43% of SMBs have been attacked, yet over half rely on untrained staff for security, highlighting a dangerous gap in preparedness.

A Phase 1 trial for Moleculin's WP1066 shows encouraging safety and anti-tumor activity for children with deadly brain tumors like DIPG.

New partnership launches TileDB Carrara on Snowflake, aiming to shatter data silos and accelerate breakthroughs in healthcare and life sciences.

NorthStar Medical Radioisotopes will showcase its revolutionary cancer-fighting isotopes, Ac-225 and Cu-67, at the prestigious J.P. Morgan conference.

Tebra's new $250M funding aims to level the playing field for private practices with AI tools that automate tasks and boost profitability.

CERo Therapeutics reports early safety success and dose escalation in its Phase 1 AML trial for CER-1236, a novel cell therapy for high-risk patients.